Femasys Incis A Biomedical Company Based In Atlantageorgiadedicated To Improving Women S Healthcare Globallythe Company Focuses On Developing Innovativeminimally Invasive Technologies For Reproductive Healthincluding Infertilitycontraceptionand Cancer Diagnosticsfemasys Operates With A Woman Led Approachemphasizing Safety And Empowerment Throughout Women S Reproductive Journeys The Company Offers Several Product Candidatesincluding Fembloca Fallopian Tube Occlusion Device For Permanent Birth Controlfemvaxan Immunotherapy Platform For Cancer Treatment Currently In Preclinical Developmentand Femcerva Cervical Cancer Screening Technologythese Products Utilize Femasysproprietary Delivery Platformallowing For Safe And Convenient In Office Procedures Without The Need For Surgical Intervention Femasys Invests Heavily In Research And Developmentwith A Significant Portion Of Its Operating Expenses Allocated To This Areathe Company Holds An Extensive Intellectual Property Portfoliofeaturing Around 200 Patents Globallywith A Commitment To Addressing Unmet Needs In Women S Healthcarefemasys Is Positioned As A Leader In The Field
